Published • loading... • Updated
Arbutus: Q4 Earnings Snapshot
Arbutus Biopharma narrowed its annual loss to $33.5 million with a $3.8 million Q4 deficit and shares closing at $4.24, reflecting ongoing financial challenges.
Summary by Washington Top News
9 Articles
9 Articles
Arbutus: Q4 Earnings Snapshot - The Morning Sun
WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Monday reported a loss of $3.8 million in its fourth quarter. On a per-share basis, the Warminster, Pennsylvania-based company said it had a loss of 1 cent. The biopharmaceutical company posted revenue of $1.1 million in the period. For the year, the company reported that its loss narrowed to $33.5 million, or 17 cents per share. Revenue was reported as $14.1 million…
·Pittsburg, United States
Read Full Article
Coverage Details
Total News Sources9
Leaning Left5Leaning Right0Center4Last UpdatedBias Distribution56% Left
Bias Distribution
- 56% of the sources lean Left
56% Left
L 56%
C 44%
Factuality
To view factuality data please Upgrade to Premium
